Complications of corneal collagen cross-linking

Corneal collagen cross-linking (CXL) is an effective treatment for arresting progression in patients with keratoconus. CXL was approved by United States Food and Drug Administration for the treatment of progressive keratoconus in 2016. It is a relatively safe procedure with a low complication rate....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Indian journal of ophthalmology 2022-05, Vol.70 (5), p.1466-1474, Article 1466
Hauptverfasser:	Agarwal, Richa, Jain, Parul, Arora, Ritu
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment Collagen Collagen - therapeutic use Complications Complications and side effects Cornea corneal collagen cross-linking Corneal diseases Cross-linking Cross-Linking Reagents - therapeutic use cxl epi-on cxl Eye Humans Keratoconus Keratoconus - diagnosis Keratoconus - drug therapy Lasers in surgery Photochemotherapy - methods post-lasik ectasia Review Surgery transepithelial cross-linking Ultraviolet Rays United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Corneal collagen cross-linking (CXL) is an effective treatment for arresting progression in patients with keratoconus. CXL was approved by United States Food and Drug Administration for the treatment of progressive keratoconus in 2016. It is a relatively safe procedure with a low complication rate. As this approach becomes more popular, it is paramount to be familiar with the potential complications associated with the procedure and its management. This article aims to report and review the complications of CXL for the treatment of keratoconus and post-LASIK ectasia.
ISSN:	0301-4738 1998-3689
DOI:	10.4103/ijo.IJO_1595_21